Xenetic Biosciences, Inc

Alere, also known as Inverness Medical, is a globally recognized healthcare consulting and management company based in Waltham, MA. Their services encompass technology solutions, collaborative care, case management, and the development of innovative products for monitoring infectious diseases, respiratory issues, drug abuse, and more. With a focus on improving healthcare outcomes, Alere provides comprehensive solutions to address a wide range of medical challenges and promote overall well-being. Their dedication to advancing healthcare technology and disease monitoring positions them as a leader in the industry. Generated from their available business information

ImmunoGen develops targeted anticancer therapeutics. The company s proprietary Tumor-Activated Prodrug technology uses tumor-targeting antibodies to deliver a potent cell-killing agent specifically to cancer cells. The company uses its technology to develop product candidates. In addition, it licenses the technology to other drug development companies. Companies that have licensed ImmunoGen s technology include Genetech; the Centocor division of Johnson & Johnson; Biogen Idec; sanofi-aventis Group; Boehringer Ingelheim; Milennium Pharmaceuticals; and Abgenix. ImmunoGen is headquartered in Cambridge, Mass., and has a manufacturing facility in Norwood, Mass. The company has more than 170 employees engaged in research and development, clinical research, manufacturing and administrative functions.

Nova Biomedical, based in Waltham, MA, specializes in the development, manufacturing, and sale of advanced analyzers across various healthcare sectors, including hospitals, critical care, and veterinary applications. The company's innovative product lineup features glucose and lactate monitoring systems, blood gas analyzers, and comprehensive solutions for cell culture analysis. Recently merged with Advanced Instruments, Nova Biomedical is committed to enhancing point-of-care testing and providing accurate results for medical professionals. The company continues to expand internationally, with significant investments in new technologies and global sales initiatives. Generated from the website